{
    "clinical_study": {
        "@rank": "153170", 
        "acronym": "ORCHESTRA", 
        "arm_group": {
            "arm_group_label": "Macitentan", 
            "arm_group_type": "Experimental", 
            "description": "Macitentan tablet, dose of 10 mg, once daily"
        }, 
        "brief_summary": {
            "textblock": "Prospective, multi-center, open-label, single-arm, Phase 3b psychometric validation study.\n\n      Primary objectives: To evaluate the psychometric characteristics of reliability and\n      construct validity of the French, Italian and Spanish versions of the PAH-SYMPACT\u2122.\n\n      To evaluate the ability of the French, Italian and Spanish versions of the PAH SYMPACT\u2122 to\n      detect change.\n\n      Secondary objective: To assess the safety of macitentan in patients with pulmonary arterial\n      hypertension (PAH).\n\n      Exploratory objective: To explore the effects of macitentan on PAH symptoms and their impact\n      (as measured by the PAH-SYMPACT\u2122) in patients with PAH in France, Italy and Spain."
        }, 
        "brief_title": "A Pulmonary Arterial Hypertension Study With Macitentan to Validate the PAH-SYMPACT\u2122 in France, Italy and Spain", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Pulmonary Arterial Hypertension (PAH)", 
        "condition_browse": {
            "mesh_term": [
                "Hypertension, Pulmonary", 
                "Hypertension"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Signed informed consent prior to initiation of any study-mandated procedure.\n\n          2. Patients with symptomatic PAH in WHO Functional Class (FC) II or III.\n\n          3. Patients with PAH belonging to one of the following subgroups of the Dana Point\n             Clinical Classification Group 1:\n\n               1. Idiopathic, or,\n\n               2. Heritable, or,\n\n               3. Drug or toxin induced, or,\n\n               4. Associated with one of the following:\n\n             i. Connective tissue disease, ii. Congenital heart disease with simple\n             systemic-to-pulmonary shunt at least 1 year after surgical repair, iii. HIV\n             infection.\n\n          4. Documented hemodynamic diagnosis of PAH by right heart catheterization - performed at\n             any time prior to Screening showing:\n\n               1. Resting mean pulmonary arterial pressure (mPAP) \u2265 25 mmHg and,\n\n               2. Resting pulmonary vascular resitance (PVR) > 240 dyn.s.cm-5 and,\n\n               3. Pulmonary capillary wede pressure (PCWP) or left ventricular end diastolic\n                  pressure (LVEDP) \u2264 15 mmHg.\n\n          5. 6-minute walk distance (6MWD) \u2265 150 m at Screening.\n\n          6. Able to fluently speak and read the local language.\n\n          7. Men or women aged 18-80; women of childbearing potential (as defined below) must:\n\n               1. Have a negative serum pregnancy test at Screening and a negative urine pregnancy\n                  test at Baseline and agree to perform monthly serum pregnancy tests, and,\n\n               2. Agree to use two reliable methods of contraception in parallel, from Screening\n                  Visit 1 until 1 month after study drug discontinuation (see details below).\n\n                    -  A female is considered to have childbearing potential unless she meets at\n                       least one of the following criteria:\n\n                         -  Previous bilateral salpingo and/or oophorectomy, or hysterectomy.\n\n                         -  Premature ovarian failure confirmed by a specialist.\n\n                         -  Pre-pubescence, XY genotype, Turner syndrome, uterine agenesis.\n\n                         -  Postmenopausal, defined as 12 consecutive months with no menses\n                            without an alternative medical cause.\n\n                    -  Of the two contraceptive methods that must be used, one must be from Group\n                       1, and one must be from Group 2, defined as follows:\n\n                         -  Group 1: Oral, implantable, transdermal or injectable hormonal\n                            contraceptives, intrauterine devices, female sterilization (tubal\n                            ligation or non surgical sterilization, e.g., permanent contraception\n                            with Essure procedure), or partner's sterilization (vasectomy). If a\n                            hormonal contraceptive is chosen from this group, it must be taken for\n                            at least 1 month prior to enrollment. Alternatively, if the Essure\n                            procedure is chosen as a contraceptive method, a hysterosalpingogram\n                            must have been performed to confirm correct location of the\n                            microinserts and tubal occlusion (as per manufacturer's\n                            recommendations).\n\n                         -  Group 2: Female or male condoms, diaphragm or cervical cap, any of\n                            them in combination with a spermicide.\n\n                    -  Sexual abstinence, rhythm methods, or contraception by the partner alone\n                       are not considered as acceptable methods of contraception for this study.\n\n        Exclusion Criteria:\n\n          1. Known moderate-to-severe obstructive lung disease (i.e., forced expiratory volume in\n             one second [FEV1] < 80 % of predicted, with FEV1 / forced vital capacity [FVC] < 70%)\n             or known significant chronic lung disease diagnosed by chest imaging (e.g.,\n             interstitial lung disease, emphysema).\n\n          2. Known moderate-to-severe restrictive lung disease (i.e., total lung capacity [TLC] <\n             60% of predicted value).\n\n          3. Hemoglobin < 100g/L at Screening.\n\n          4. Serum aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT) > 3 X\n             upper limit of the normal range (ULN) at Screening.\n\n          5. Patients undergoing dialysis.\n\n          6. Systolic blood pressure (SBP) < 90 mmHg at Screening.\n\n          7. Body weight < 40 kg at Screening.\n\n          8. Known concomitant life-threatening diseases with a life expectancy of < 12 months.\n\n          9. Treatment with ERAs within 3 months prior to Visit 2, or scheduled to receive any of\n             these compounds, other than macitentan, during the trial.\n\n         10. Treatment with intravenous or subcutaneous prostacyclin or prostacyclin analogs\n             within 3 months prior to Visit 2, or scheduled to receive any of these compounds\n             during the trial.\n\n         11. Treatment with soluble guanylate cyclase stimulator (riociguat) within 3 months prior\n             to Visit 2, or scheduled to receive riociguat during the trial.\n\n         12. Patients who changed the dose of or discontinued phosphodiesterase type-5 inhibitor\n             (PDE5i), inhaled prostacyclin analogues, or calcium channel blockers within 3 months\n             prior to Visit 2.\n\n         13. Initiation of diuretics within 1 week prior to the Baseline period.\n\n         14. Patients on oral diuretics in whom the dose has not been stable for at least 1 week\n             prior to the Baseline period.\n\n         15. Treatment with cytochrome P4500 (CYP) 3A inducers within 4 weeks prior to Visit 2.\n\n         16. Recently started (< 8 weeks prior to Visit 2) or planned cardio-pulmonary\n             rehabilitation program based on exercise.\n\n         17. Females who are lactating or pregnant (positive Screening or Baseline pregnancy test)\n             or plan to become pregnant during the study.\n\n         18. Known hypersensitivity to macitentan or its excipients or drugs of the same class.\n\n         19. Treatment with another investigational drug within 3 months prior to Visit 2.\n\n         20. Any known factor or disease that might interfere with treatment compliance, study\n             conduct or interpretation of the results such as drug or alcohol dependence or\n             psychiatric disease."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02081690", 
            "org_study_id": "AC-055-310"
        }, 
        "intervention": {
            "arm_group_label": "Macitentan", 
            "description": "Macitentan tablet, dose of 10 mg, once daily", 
            "intervention_name": "Macitentan", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "May 9, 2014", 
        "location": [
            {
                "contact": {
                    "email": "claire.dromer@chu-bordeaux.fr", 
                    "last_name": "Claire Dromer", 
                    "phone": "33557656189"
                }, 
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France", 
                        "zip": "33604"
                    }, 
                    "name": "H\u00f4pital de Haut Lev\u00eaque"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "bergot-e@chu-caen.fr", 
                    "last_name": "Emmanuel Bergot", 
                    "phone": "33 2 31064677"
                }, 
                "facility": {
                    "address": {
                        "city": "Caen", 
                        "country": "France", 
                        "zip": "14033"
                    }, 
                    "name": "H\u00f4pital C\u00f4te de Nacre"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "cpison@chu-grenoble.fr", 
                    "last_name": "Christophe Pison", 
                    "phone": "+33-4-76765834"
                }, 
                "facility": {
                    "address": {
                        "city": "Grenoble", 
                        "country": "France", 
                        "zip": "38700"
                    }, 
                    "name": "H\u00f4pital Albert Michallon"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "laurent.savale@gmail.com", 
                    "last_name": "Laurent Savale", 
                    "phone": "33145217991"
                }, 
                "facility": {
                    "address": {
                        "city": "Le Kremlin-Bic\u00eatre", 
                        "country": "France", 
                        "zip": "94270"
                    }, 
                    "name": "CHU de Bic\u00eatre"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "pascal.degroote@chru-lille.fr", 
                    "last_name": "Pascal DeGroote", 
                    "phone": "+33 3 20 44 57 21"
                }, 
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France", 
                        "zip": "59037"
                    }, 
                    "name": "CHRU Lille - H\u00f4pital Cardiologique"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "vincent.cottin@chu-lyon.fr", 
                    "last_name": "Vincent Cottin", 
                    "phone": "33472357072"
                }, 
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69677"
                    }, 
                    "name": "H\u00f4pital Louis Pradel"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "arnaud01009157@gmail.com", 
                    "last_name": "Arnaud Bourdin", 
                    "phone": "+33 4 67 33 60 91"
                }, 
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34295"
                    }, 
                    "name": "H\u00f4pital Arnaud de Villeneuve"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "f.chabot@chu-nancy.fr", 
                    "last_name": "Jean-Francois Chabot", 
                    "phone": "+33-3-83154021"
                }, 
                "facility": {
                    "address": {
                        "city": "Nancy", 
                        "country": "France", 
                        "zip": "54511"
                    }, 
                    "name": "H\u00f4pitaux de Brabois"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "celine.chabanne@chu-rennes.fr", 
                    "last_name": "C\u00e9line Chabanne", 
                    "phone": "+33-2-99282519"
                }, 
                "facility": {
                    "address": {
                        "city": "Rennes", 
                        "country": "France", 
                        "zip": "35033"
                    }, 
                    "name": "H\u00f4pital Pontchaillou"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "fabrice.bauer@chu-rouen.fr", 
                    "last_name": "Fabrice Bauer", 
                    "phone": "+33-2-32888232"
                }, 
                "facility": {
                    "address": {
                        "city": "Rouen", 
                        "country": "France", 
                        "zip": "76031"
                    }, 
                    "name": "H\u00f4pital Charles Nicolle"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "laurent.bertoletti@gmail.com", 
                    "last_name": "Laurent Bertoletti", 
                    "phone": "+33-4-77127770"
                }, 
                "facility": {
                    "address": {
                        "city": "Saint-Etienne", 
                        "country": "France", 
                        "zip": "42227"
                    }, 
                    "name": "H\u00f4pital Nord"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "matthieu.canuet@chru-strasbourg.fr", 
                    "last_name": "Matthieu Canuet", 
                    "phone": "33 3 6955 0645"
                }, 
                "facility": {
                    "address": {
                        "city": "Strasbourg", 
                        "country": "France", 
                        "zip": "67091"
                    }, 
                    "name": "H\u00f4pital Civil"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "prevot.g@chu-toulouse.fr", 
                    "last_name": "Gr\u00e9goire Pr\u00e9vot", 
                    "phone": "335677717 09"
                }, 
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31059"
                    }, 
                    "name": "H\u00f4pital Larrey"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "nazzareno.galie@unibo.it", 
                    "last_name": "Nazzareno Gali\u00e8", 
                    "phone": "+39 0516363536"
                }, 
                "facility": {
                    "address": {
                        "city": "Bologna", 
                        "country": "Italy", 
                        "zip": "40138"
                    }, 
                    "name": "Ospedale Sant'Orsola"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "chiarcangeli@yahoo.it", 
                    "last_name": "Chiara Arcangeli", 
                    "phone": "+39-347-6290100"
                }, 
                "facility": {
                    "address": {
                        "city": "Firenze", 
                        "country": "Italy", 
                        "zip": "50124"
                    }, 
                    "name": "A.O.U.C. Careggi"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "zip": "00186"
                    }, 
                    "name": "Centro Per La Diagnosi E La Cura Dell'Ipertensione Polmonare"
                }, 
                "status": "Enrolling by invitation"
            }, 
            {
                "contact": {
                    "email": "jgc01a@saludalia.com", 
                    "last_name": "Gil Carbonell", 
                    "phone": "34618840520"
                }, 
                "facility": {
                    "address": {
                        "city": "Alicante", 
                        "country": "Spain", 
                        "zip": "03010"
                    }, 
                    "name": "Hospital General de Alicante"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "manuelop@vhebron.net", 
                    "last_name": "Manuel Lopez Meseguer", 
                    "phone": "34932746000; Ext: 6208"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08035"
                    }, 
                    "name": "Hospital Val Hebron"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jbarbera@clinic.ub.es", 
                    "last_name": "Joan Albert Barbera Mir", 
                    "phone": "34932275747"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08036"
                    }, 
                    "name": "Hospital Clinic"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mvictoria.egurbidearberas@osakidetza.net", 
                    "last_name": "Victoria Egurbide Astobiza", 
                    "phone": "34946006348"
                }, 
                "facility": {
                    "address": {
                        "city": "Bilbao", 
                        "country": "Spain", 
                        "zip": "48903"
                    }, 
                    "name": "Hospital de Cruces"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "fsantos1957@hotmail.com", 
                    "last_name": "Francisco Santos Luna", 
                    "phone": "34957010411"
                }, 
                "facility": {
                    "address": {
                        "city": "C\u00f3rdoba", 
                        "country": "Spain", 
                        "zip": "14004"
                    }, 
                    "name": "Hospital Reina Sofia"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "juanjo.rios@gmail.com", 
                    "last_name": "Juan Jose Rios Blanco", 
                    "phone": "34630064677"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28046"
                    }, 
                    "name": "Hospital La Paz"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "pilar.escribano@telefonica.net", 
                    "last_name": "Pilar Escribano Subias", 
                    "phone": "34913908669"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28041"
                    }, 
                    "name": "Hospital 12 Octubre"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "ederamongm2@gmail.com", 
                    "last_name": "Enrique de Ram\u00f3n", 
                    "phone": "34630373364"
                }, 
                "facility": {
                    "address": {
                        "city": "Malaga", 
                        "country": "Spain", 
                        "zip": "29010"
                    }, 
                    "name": "Hospital Carlos Haya"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Ernest.sala@ssib.es", 
                    "last_name": "Ernest Sala Llinas", 
                    "phone": "34871 206507 ext 76507"
                }, 
                "facility": {
                    "address": {
                        "city": "Palma de Mallorca", 
                        "country": "Spain", 
                        "zip": "7010"
                    }, 
                    "name": "Hospital Son Espases"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jmcifrian@humv.es", 
                    "last_name": "Jose Manuel Cifrian Martinez", 
                    "phone": "34696 859 471"
                }, 
                "facility": {
                    "address": {
                        "city": "Santander", 
                        "country": "Spain", 
                        "zip": "39008"
                    }, 
                    "name": "Hospital de Valdecilla"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "rotero@separ.es", 
                    "last_name": "Remedios Otero Candelera", 
                    "phone": "34955013172"
                }, 
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "41013"
                    }, 
                    "name": "Hospital Virgen del Rocio"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Gustavo.Juan@uv.es", 
                    "last_name": "Gustavo Juan Samper", 
                    "phone": "34961972230"
                }, 
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain", 
                        "zip": "46014"
                    }, 
                    "name": "Hospita General U. Valencia"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Italy", 
                "Spain"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the French, Italian and Spanish Versions of the PAH-SYMPACT\u2122", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "France: Committee for the Protection of Personnes", 
                "France: Conseil National de l'Ordre des M\u00e9decins", 
                "Italy: Ethics Committee", 
                "Italy: The Italian Medicines Agency", 
                "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
                "Spain: Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Evaluation of the psychometric characteristics of reliability and construct validity of the PAH-SYMPACT, and the ability of the PAH-SYMPACT to detect change.", 
                "measure": "Psychometric validation of the French, Italian and Spanish versions of the PAH-SYMPACT\u2122 patient-reported outcome tool", 
                "safety_issue": "Yes", 
                "time_frame": "From Screening Visit (Visit 1) to End of Treatment (EOT) Visit (Visit 4, Week 16)"
            }, 
            {
                "description": "Change in the PAH-SYMPACT symptom and impact scores assessed by the PAH-SYMPACT questionnaire.", 
                "measure": "Change in the PAH-SYMPACT symptom and impact scores", 
                "safety_issue": "No", 
                "time_frame": "From Baseline Visit (Visit 2, Day 1) to Week 8 and from Baseline  Visit to Week 16"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02081690"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Frequency of treatment-emergent adverse events (AEs); AEs leading to premature discontinuation of study drug; treatment emergent serious adverse events (SAEs); change from Baseline to Week 16 in vital signs; treatment-emergent liver aminotransferase abnormalities (\uff1e3, \uff1e5, and \uff1e8 X upper limit of normal) associated or not with total bilirubin \uff1e2 X upper limit of normal; treatment-emergent hemoglobin abnormality (\u2266100 g/L and \u226680 g/L).", 
            "measure": "Assessment of the safety of macitentan", 
            "safety_issue": "Yes", 
            "time_frame": "From Screening Visit (Visit 1) to End of Treatment (EOT) Visit (Visit 4, Week 16)"
        }, 
        "source": "Actelion", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Actelion", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}